FDA Inspection 1049653 — Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
The FDA completed an inspection of Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. on Mar 23, 2018 in Tokushima. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tokushima (Japan)